MedTrace Logo

Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors

NCT06143605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 527

Last updated 2023-11-22

No results posted yet for this study

Summary

we evaluated all related clinical and pathologic data of rectal NET cases, including the resection margin status, NET grading, and lymphovascular invasion status. Finally, the present study was aimed at (1) determining the risk factors for LN and distant metastases in colorectal NETs (2) clarifying the clinical significance of the salvage treatment for colorectal neuroendocrine tumors following initial endoscopic resection with positive resection margin status and (3) compare different salvage treatment of this uncommon disease through conducting a large, multi-center cohort study.

Conditions

Interventions

PROCEDURE

salvage treatment

salvage radical surgery or endoscopic resection

Sponsors & Collaborators

  • Yanhong Deng

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-30
Primary Completion
2022-12-30
Completion
2023-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06143605 on ClinicalTrials.gov